- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02814812
Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery
December 13, 2019 updated by: CHU de Reims
Pancreatectomy represents the classic approach for resectable lesions of the pancreas, duodenum and periampullary region.
Due to the technical skills required, the complex anatomy and the extreme fragility of the pancreatic parenchyma, pancreatic resection is still considered to be at risk of postoperative complication mainly due to pancreatic juice leaks.
Anastomotic leaks are the major cause of morbidity and in-hospital mortality due to the activation of pancreatic enzymes and the following infectious and hemorrhagic complications.
Severe complications negatively affect postoperative outcomes, long-term survival, quality of life, and costs.
Operative mortality traditionally has been defined as the rate within 30 days or during the initial hospitalization.
But in pancreatic surgery mortality rates within 90 days after pancreatic resection are double those at 30 days.
In the present study, the investigators sought to evaluate the usefulness of postoperative CT-scan on the seventh postoperative day before discharging the patients to detect undiagnosed postoperative complication.
Study Overview
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Reims, France, 51092
- CHU Reims
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Will be included in this study, patients:
- Having an indication of pancreatic surgery
- In scheduled surgery
- Agreeing to participate in the research (ie who signed the informed consent to research participation)
- >18yo
Exclusion Criteria:
Will not be included in this study, patients:
- With emergency surgery
- Protected by law
- Under 18 years
- Presenting an against-indications to the scanner: documented severe allergy to contrast material, kidney failure against-showing the contrast medium injection, pregnancy, lactation and/or MRI (pacemaker, metallic intraocular foreign body)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: pancreatic surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
detection of undiagnosed postoperative complication by CT scan
Time Frame: Day 7
|
Day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
June 16, 2016
First Submitted That Met QC Criteria
June 23, 2016
First Posted (Estimate)
June 28, 2016
Study Record Updates
Last Update Posted (Actual)
December 16, 2019
Last Update Submitted That Met QC Criteria
December 13, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PO14086
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatectomy
-
Washington University School of MedicineTerminated
-
Mayo ClinicCompletedPancreatectomyUnited States
-
National Cheng-Kung University HospitalRecruiting
-
Universidad de ExtremaduraCompletedDistal Pancreatectomy
-
Mayo ClinicTerminated
-
Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral-...University of Kaiserslautern-Landau; Deutsches Forschungszentrum für Künstliche...RecruitingFeasibility and Effectiveness of Augmented Reality Assistance System for Pancreatic Surgery (ARAS-P)Pancreatectomy | Augmented RealityGermany
-
Polyganics BVGenaeCompletedPancreatectomy | Hepatic ResectionGermany
-
University Hospital, MontpellierCompleted
-
Seoul National University Bundang HospitalCompletedFluid Therapy | Laparoscopy | Pancreatectomy
-
Peking Union Medical College HospitalUnknownPancreatectomy | Post Procedural DischargeChina
Clinical Trials on CT scan
-
Amsterdam UMC, location VUmcMRIguidance B.V.CompletedSinusitis | Hearing Loss | Head and Neck Tumor | Cholesteatoma | Imaging of Bony Structures of the Head (Various Conditions)Netherlands
-
ElsanRecruitingTotal Occlusion of Coronary ArteryFrance
-
University Hospital, AntwerpCompleted
-
University of RochesterNational Cancer Institute (NCI)Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...Enrolling by invitationAortic Valve Stenosis | Heart Valve Diseases | Aortic Regurgitation | Aortic Valve Insufficiency | Aortic Stenosis, Severe | Regurgitation, Aortic | Stenoses, Aortic | Coronary; Obstruction | Valve Disease, AorticItaly
-
University Hospital AugsburgRecruitingNeoplasms | Neoplasm Metastasis | Metastatic CancerGermany
-
Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term CareCompletedAdenocarcinoma | Cervical Cancer | Squamous Cell Carcinoma | Adenosquamous CarcinomaCanada
-
NureaWithdrawn
-
NureaCompletedAortic AneurysmFrance
-
European Institute of OncologyAssociazione Italiana per la Ricerca sul CancroCompletedSubjects at High Risk of Lung Cancer Due to SmokingItaly